TABLE III.

Multivariate Analysis of the Association of ERG Protein Expression Intensity With Clinical Outcomes as Assessed by Both Anti-ERG Antibodies

Clinical outcome	EPR3864 ERG nuclear intensity (n)	P-value	9FY ERG nuclear intensity (n)	P-value
Biochemical relapse
No	1.03 (48)	0.0002	1.01 (44)	0.0040
Yes	2.00 (29)		1.83 (28)
Local recurrence
No	1.17 (74)	0.0026	1.18 (69)	0.0070
Yes	2.84 (3)		2.77 (3)
Distant metastases
No	0.97 (48)	0.011	0.99 (44)	0.027
Yes	1.64 (29)		1.59 (28)
PCSM
No	1.01 (50)	<0.0001	0.97 (56)	0.0002
Yes	2.30 (17)		2.09 (16)